How do you pay?

How to pay the least

Ask for the cash price

Cyltezo

Cyltezo is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

What to do

  1. Ask your pharmacy for Cyltezo’s cash price, and one or two other pharmacies too.

Compare every option

Brand name

Cyltezo, the original

Cash priceAsk the pharmacy

We didn’t find a savings card or cash price from Cyltezo’s maker. Ask the pharmacy for Cyltezo’s cash price. With insurance, ask what your plan charges.

Authorized generic

There isn’t one.

Not soldThere isn’t one

Regular generic

Cyltezo is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

Not soldAsk the pharmacy

What it’s used for

What the FDA label says

CYLTEZO is a tumor necrosis factor (TNF) blocker indicated for:

  • Reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis.
  • Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older.
  • Reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic arthritis.
  • Reducing signs and symptoms in adult patients with active ankylosing spondylitis.
  • Treatment of moderately to severely active Crohn's disease in adults and pediatric patients 6 years of age and older.
  • Treatment of moderately to severely active ulcerative colitis in adult patients. Limitations of Use: Effectiveness has not been established in patients who have lost response to or were intolerant to TNF blockers.
  • Treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate.
  • Treatment of moderate to severe hidradenitis suppurativa in patients 12 years of age and older.
  • Treatment of non-infectious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older.

Source: the FDA label for Cyltezo (Boehringer Ingelheim Pharmaceuticals, Inc.), May 22, 2026. Full label on DailyMed 

Good to know

  • We didn’t find a savings card from Cyltezo’s maker.
  • Don’t stop or change a medicine without talking to your pharmacist or prescriber.